Role of mannose-binding lectin (MBL2) genotyping in predicting the risk of recurrent otitis media (rOM)

Advances in Experimental Medicine and Biology

Volumn 586, Issue , 2006, Pages 281-290

  Nuytinck, Lieve ^a   De Meester, Els ^a   Van Thielen, Martine ^a   Govaerts, Paul ^b  

^a INNOGENETICS   (Belgium)

^b Ear Group   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84934442481     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/0-387-34134-X_19     Document Type: Conference Paper

References (17)

1. Boldt AB, Petzl-Erler ML. A new strategy for mannose-binding lectin gene haplo-typing. Hum Mutat 19(3):296-306 (2002).
2. Casselbrant ML, Mandel EM. The genetics of otitis media. Curr Allergy Asthma Rep 1(4):353-357 (2001).
3. Casselbrant ML, Mandel EM. Genetic susceptibility to otitis media. Curr Opin Allergy Clin Immunol 5(1):1-4 (2005).
4. Daly KA, Brown WM, Segade F, Bowden DW, Keats BJ, Lindgren BR, Levine SC, Rich SS. Chronic and recurrent otitis media: a genome scan for susceptibility loci. Am J Hum Genet 75(6):988-997 (2004).
5. den Dunnen JT, Antonarakis SE. Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion. Hum Mutat 15(1):7-12 (2000).
6. Garred P, Brygge K, Sorensen CH, Madsen HO, Thiel S, Svejgaard A. Mannan-binding protein - levels in plasma and upper-airways secretions and frequency of genotypes in children with recurrence of otitis media. Clin Exp Immunol 94(1):99-104 (1993).
7. Homoe P, Madsen HO, Sandvej K, Koch A, Garred P. Lack of association between mannose-binding lectin, acute otitis media and early Epstein-Barr virus infection among children in Greenland. Scand J Infect Dis 31(4):363-366 (1999).
8. Madsen HO, Garred P, Kurtzhals JA, Lamm LU, Ryder LP, Thiel S, Svejgaard A. A new frequent allele is the missing link in the structural polymorphism of the human mannan-binding protein. Immunogenetics 40(1):37-44 (1994).
9. Madsen HO, Garred P, Thiel S, Kurtzhals JA, Lamm LU, Ryder LP, Svejgaard A. Interplay between promoter and structural gene variants control basal serum level of mannan-binding protein. J Immunol 155(6):3013-3020, 1995.
10. Medzhitov R, Janeway C Jr. Innate immunity. N Engl J Med 343(5):338-344 (2000).
11. Nuytinck L, Shapiro F. Mannose-binding lectin: laying the stepping stones from clinical research to personalized medicine. Personalized Med 1(1):35-52 (2004)
12. Rich SS, Daly K, Levine SC. Familial aggregation and risk factors for chronic recurrent otitis media. In: Recent advances in otitis media: proceedings of the sixth international symposium 1995 BCDecker (Hamilton), 65-68 (1996).
13. Straetemans M, Wiertsema SP, Sanders EA, Rijkers GT, Graamans K, Van Der Baan B, Zielhuis GA. Immunological status in the aetiology of recurrent otitis media with effusion: serum immunoglobulin levels, functional mannose-binding lectin and fc receptor polymorphisms for IgG. J Clin Immunol 25(1):78-86 (2005).
14. Sullivan KE, Wooten C, Goldman D, Petri M. Mannose-binding protein genetic polymorphisms in black patients with systemic lupus erythematosus. Arthritis Rheum 39(12):2046-2051 (1996).
15. Tezcan I, Yilmaz Y, Oner F, Yel L, Sanal O, Ersoy F, Onerci M, Berkel AI. Defective serum opsonization activity in children aged 6-48 months having acute purulent otitis media. Turk J Pediatr 39(4):453-457 (1997).
16. Thiel S, Frederiksen PD, Jensenius JC. Clinical manifestations of mannan-binding lectin deficiency. Mol Immunol 43(1-2):86-96 (2006)
17. Turner MW. The role of mannose-binding lectin in health and disease. Mol Immunol 40(7):423-429 (2003).